Quetiapine Fumarate
Is It Right for You?
A complete guide to Quetiapine Fumarate — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Quetiapine Fumarate?
Quetiapine fumarate is an atypical (second-generation) antipsychotic medication available in two distinct formulations: immediate-release (IR) tablets (25 mg, 100 mg, 150 mg, 200 mg, and 300 mg) requiring twice-daily dosing, and extended-release (XL) tablets (50 mg, 150 mg, 200 mg, 300 mg, and 400 mg) taken once daily. It is one of the most widely prescribed antipsychotics globally, licensed across a broad range of serious psychiatric conditions.
Developed by AstraZeneca, quetiapine acts on multiple neurotransmitter systems — principally dopamine and serotonin — but also histamine, adrenergic, and muscarinic receptors, producing its broad spectrum of clinical effects. This multi-receptor pharmacology distinguishes atypical antipsychotics from older first-generation agents and is associated with a more favourable side effect profile, particularly with respect to movement disorders (extrapyramidal side effects).
Quetiapine is used as a first-line treatment in schizophrenia and bipolar disorder, and as an adjunct in treatment-resistant depression. It requires careful initiation, dose titration, and ongoing monitoring due to its metabolic and cardiovascular effects.
Quetiapine fumarate is a prescription-only medication in the UK. It must only be initiated and monitored by a licensed clinician, typically in consultation with or under the supervision of a psychiatrist for new diagnoses.
What Conditions Is Quetiapine Fumarate Used For?
Quetiapine fumarate is indicated for:
acute and maintenance treatment of positive symptoms (hallucinations, delusions, disorganised thinking) and negative symptoms (apathy, social withdrawal, emotional blunting)
acute treatment of moderate-to-severe mania
treatment of the depressive phase of bipolar disorder (quetiapine is one of the few agents with robust evidence in bipolar depression)
Quetiapine is not a simple sedative or sleeping aid. While its sedative properties are sometimes misused in this context, it carries significant metabolic, cardiac, and neurological risks that require proper clinical oversight. It should only ever be prescribed and used for licensed indications following thorough psychiatric assessment.
How Does Quetiapine Fumarate Work?
Quetiapine exerts its therapeutic effects through antagonism of multiple receptor systems:
Dopamine D2 receptor blockade in mesolimbic pathways is the primary mechanism underlying antipsychotic efficacy — reducing excessive dopaminergic activity that drives psychotic symptoms such as hallucinations and delusions. Quetiapine's relatively low D2 affinity and fast receptor dissociation (compared to first-generation antipsychotics) is thought to account for its low propensity to cause extrapyramidal side effects and tardive dyskinesia.
Serotonin 5-HT2A receptor antagonism modulates dopamine release in the nigrostriatal and mesocortical pathways, further reducing extrapyramidal effects and contributing to improvement in mood and negative symptoms.
Histamine H1 receptor antagonism produces the sedation and appetite stimulation associated with quetiapine — effects that are clinically useful for sleep disturbance and agitation but contribute to weight gain and somnolence as side effects.
Alpha-1 adrenoceptor blockade contributes to orthostatic hypotension — a clinically important risk, particularly at initiation.
Muscarinic receptor antagonism (mild) contributes to dry mouth and constipation.
The extended-release formulation achieves smoother plasma concentration profiles, reducing peak-related side effects and enabling once-daily dosing, which supports adherence.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
XL tablets must be swallowed whole — do not crush, split, or chew. This destroys the extended-release mechanism.
IR tablets can be taken with or without food. XL tablets are best taken without a high-fat meal, which significantly increases absorption and could raise plasma levels unexpectedly.
Titrate slowly. Dose increases should follow the prescribed titration schedule — rapid escalation increases the risk of orthostatic hypotension, sedation, and other side effects.
Take quetiapine at the same time(s) each day. Evening dosing is common as it leverages sedative properties to support sleep.
Do not stop quetiapine abruptly. Discontinuation should be gradual and supervised — abrupt withdrawal can cause insomnia, nausea, vomiting, and rebound psychiatric symptoms.
Side Effects of Quetiapine Fumarate
Quetiapine has a broad side effect profile reflecting its multi-receptor pharmacology. Metabolic side effects are the most clinically significant over the long term.
- Somnolence / drowsiness (particularly at initiation and with dose increases)
- Dizziness and postural hypotension — risk of falls
- Dry mouth
- Constipation
- Headache
- Weight gain — often significant with long-term use
- Neuroleptic malignant syndrome (NMS) — high fever, severe muscle rigidity, altered consciousness, autonomic instability; rare but life-threatening; discontinue immediately and seek emergency care.
- Tardive dyskinesia — involuntary, repetitive facial or limb movements with prolonged use; may be irreversible.
Long-term quetiapine use is associated with significant weight gain and metabolic disturbance. Regular monitoring of weight, waist circumference, fasting blood glucose, HbA1c, and lipids is essential throughout treatment.
Drug Interactions
Quetiapine may interact with other medications, including MAOIs, CNS depressants, and strong CYP3A4 inducers. Always inform your clinician about all medications you are taking.
Additive QT prolongation; risk of potentially fatal Torsades de Pointes. Concurrent use requires careful review and cardiac monitoring.
Additive CNS and respiratory depression; enhanced sedation. Concurrent use greatly increases the risk of over-sedation and respiratory compromise.
Markedly reduce quetiapine plasma levels, potentially rendering treatment ineffective. Avoid concurrent use; if unavoidable, substantial quetiapine dose increases may be required.
Substantially increase quetiapine plasma concentrations; significantly elevated risk of side effects. Dose reduction is required.
Important Warnings
Antipsychotic medications — including quetiapine — are associated with an increased risk of mortality and stroke when used in elderly patients with dementia-related psychosis. Quetiapine is not licensed for this use. If prescribed off-label in this population, it must be under careful specialist supervision with a documented risk-benefit discussion.
NMS is a rare but potentially fatal reaction to antipsychotics. Seek emergency care immediately if high fever, severe muscle rigidity, altered mental state, or autonomic instability (rapid pulse, unstable blood pressure, sweating) develops. Discontinue quetiapine immediately.
As with other psychiatric medications, patients — particularly those under 25 — should be monitored closely for any worsening of mood, new thoughts of self-harm, or increased agitation during initiation and dose changes.
Quetiapine commonly causes clinically significant weight gain and metabolic disturbance. Baseline and regular monitoring of weight, BMI, fasting glucose, HbA1c, and lipids is mandatory throughout treatment.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Quetiapine Fumarate FAQs
Immediate-release quetiapine is taken twice daily and produces higher peak plasma levels. Extended-release quetiapine (XL) is taken once daily and produces a smoother plasma concentration profile, reducing peak-related side effects and improving adherence. For most indications, XL is now preferred.
Weight gain is a recognised and common side effect, particularly at higher doses and with long-term use. Monitoring weight regularly, maintaining a healthy diet, and staying physically active are important throughout treatment.
Quetiapine's sedative properties are sometimes prescribed off-label for insomnia, but this practice is not recommended. Its metabolic, cardiac, and neurological risks make it an inappropriate choice for sleep problems when safer, evidence-based alternatives are available.
Quetiapine should never be stopped abruptly. Always taper gradually under your clinician's supervision. The rate of taper will depend on the dose, duration of treatment, and the indication for which it was prescribed.
Yes — quetiapine can raise blood glucose and is associated with an increased risk of new-onset type 2 diabetes. Fasting glucose and HbA1c should be monitored regularly throughout treatment, and any symptoms of diabetes (excessive thirst, increased urination, unexplained weight loss) should be reported to your clinician.